SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia
6 references·4 citing·35 second hop
Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia (2017)Reconsideration of blood donation testing…Cost‐effectiveness of additional blood screening tests in the Netherlands (2011)Cost‐effectiveness of additio…Blood safety strategies for human T‐cell lymphotropic virus in Europe (2008)Blood safety strategies for h…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Assessing the accuracy of thr…The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples 1999 (1999)The health and welfare of Aus…Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis (1998)Screening for human T cell le…Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework. (2019)Malaria blood safety policy i…Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection (2019)Health economic implications …Risk‐based decision making in transfusion medicine (2018)Risk‐based decision making in…Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada (2018)Human T‐cell lymphotropic vir…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The NICE Cost-Effectiveness Threshold (2008)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Blood donor selection in European Union directives: room for improvement. (2016)Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis (2018)Modelling the risk of transfusion‐transmitted syphilis: a reconsideration of blood donation testing strategies (2018)Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus (2008)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Current risk for transfusion transmitted infections (2007)Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (2007)Informative Dorfman Screening (2011)Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery (1992)Human T‐lymphotropic virus antibody screening of blood donors: rates of false‐positive results and evaluation of a potential donor reentry algorithm (2010)Surveillance of Transfusion-Transmissible Infections (2011)Transfusion sanguine : en toute sécurité infectieuse (2014)From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking (2012)Risk and the limits of governance: Exploring varied patterns of risk‐based governance across E urope (2012)Challenges in the management of the blood supply (2013)The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands (2011)Cost–effectiveness thresholds: pros and cons (2016)Income Elasticities and Global Values of a Statistical Life (2017)Overview of revised measures to prevent malaria transmission by blood transfusion in France (2008)Risk for malaria in United States donors deferred for travel to malaria‐endemic areas (2009)Donor deferral policies for men who have sex with men: past, present and future (2017)Bullying in school: are short pupils at risk? Questionnaire study in a cohort (2000)False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors (2006)Addressing the health disadvantage of rural populations: How does epidemiological evidence inform rural health policies and research? (2008)Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap (2008)A review of life expectancy and infant mortality estimations for Australian Aboriginal people (2014)
this work references cited by second hop

References

  • 1999The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples 1999800 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2002Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT78 cited
  • 2008Blood safety strategies for human T‐cell lymphotropic virus in Europe75 cited
  • 1998Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis41 cited
  • 2011Cost‐effectiveness of additional blood screening tests in the Netherlands35 cited

Cited by

  • 2018Risk‐based decision making in transfusion medicine22 cited
  • 2019Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework.21 cited
  • 2018Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada13 cited
  • 2019Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection11 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work